Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Pluristem Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

19 Aug 2016 Reuters Investment Profile 12 $20.00

Pluristem Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

19 Aug 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Pluristem Therapeutics Inc (PSTI-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

26 Aug 2016 Thomson Reuters Stock Report 12 $25.00

Pluristem Therapeutics Inc. (PSTI) - Financial Analysis Review

Pluristem Therapeutics Inc. (PSTI) - Financial Analysis Review Summary Pluristem Therapeutics Inc. (Pluristem) is a biotechno...

22 Aug 2016 GlobalData 49 $300.00

PLURISTEM THERAPEUTICS INC (PSTI=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

20 Aug 2016 Pechala's Reports 2 $25.00

Value Graph: PLURISTEM THERAP -- PSTI

19 Aug 2016 Ford Investor Services, Inc. 1 $12.00

ValuEngine Rating and Forecast Report for PSTI

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

14 Aug 2016 ValuEngine, Inc. 11 $25.00

Wright Investors Service Comprehensive Report for Pluristem Therapeutics Incorporation.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

29 Jul 2016 Wright Reports 61 $75.00

Pluristem Therapeutics Inc.: Downgraded to Above Average

17 Jun 2016 Sadif Analytics Prime 3 $10.00

Pluristem Therapeutics Inc. (PSTI) - Financial Analysis Review

Pluristem Therapeutics Inc. (PSTI) - Financial Analysis Review Summary Pluristem Therapeutics Inc. (Pluristem) is a biotechno...

15 Jun 2016 GlobalData 51 $300.00